- cafead   Jun 28, 2023 at 10:02: AM
via Watch out, Novo Nordisk. Lilly’s retatrutide, a so-called triple G, has bettered not only Novo’s Wegovy but Lilly’s own Mounjaro when data from three different obesity trials are compared. The project allowed obese patients to lose nearly a quarter of their bodyweight after around a year’s treatment.
article source
article source